PRINCIPAL ACCOUNTING OFFICER · ACADIA PHARMACEUTICALS INC · ACADIA PHARMACEUTICALS INC — Restricted Stock Units
Side
M
Value
—
Shares
2,010
Price
—
Executed
Apr 5, 2026
Disclosed
Apr 7, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Apr 5 executedApr 7, 2026 disclosed
ACAD · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Option exercise — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+4 / 15
4 prior trades recorded in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
ACADIA PHARMACEUTICALS INC — Restricted Stock Units
Ticker
ACAD
Shares
2,010
Price per share
$0
Execution date (reported)
Apr 5, 2026
Owned after transaction
0 shares
Days from execution to publication
2
What this establishes
Kihara James filed this Form 4 reporting a option exercise of ACAD on Apr 5, 2026. It became public on Apr 7, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
PRINCIPAL ACCOUNTING OFFICER
Kihara Jamescik:0001816160
Issuer
ACADIA PHARMACEUTICALS INCcik:0001070494
Revision history · 0
No field has changed since this record was first ingested.
